Home › Bile Duct Cancer (Cholangiocarcinoma) › New York › New York City
Pag-aaral pangklinika para sa Bile Duct Cancer (Cholangiocarcinoma) sa New York City, NY
Isang pag-aaral para sa Bile Duct Cancer (Cholangiocarcinoma) ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa New York City. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
A Study of PHST001 in Advanced Solid Tumors
Nagre-recruitPhase 1
- Mount Sinai, New York
A Study to Select a Dose Regimen (Part A) and to Investigate Overall Survival (Part B) With Nanvuranlat Compared With Physician's Best Choice in Participants Aged 18 Years or Older With Biliary Tract Cancer
Nagre-recruitPhase 3
- Memorial Sloan Kettering Cancer Center (Site 108), New York
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
Nagre-recruitPhase 1
- New York University (NYU) Clinical Cancer Center, New York
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract Cancer
Nagre-recruitPhase 3
- Memorial Sloan Kettering Cancer Centers, New York
Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors
Nagre-recruitPhase 1/2
- New York University Langone Health, New York
Gemcitabine and Oxaliplatin Chemotherapy With or Without a Floxuridine and Dexamethasone Pump in People With Cholangiocarcinoma That Cannot Be Removed With Surgery
Nagre-recruitPhase 2
- Memorial Sloan Kettering Cancer Center, New York
Olutasidenib DDI Study in Patients With IDH1 Mutation Positive Malignancies
Nagre-recruitPhase 4
- New York Presbyterian Hospital-Columbia University Medical Center, New York
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
Nagre-recruitPhase 2
- Columbia University Irving Medical Center, New York
- Memorial Sloan Kettering Cancer Center, New York
A Study of MGC028 in Participants With Advanced Solid Tumors
Nagre-recruitPhase 1
- Icahn School of Medicine at Mt. Sinai, New York
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Nagre-recruitObservasyonal na pag-aaral
- Massive Bio SYNERGY-AI site, New York
The Dragon PLC Trial (DRAGON-PLC)
Nagre-recruit
- Memorial Sloan Kettering Cancer Center, New York
Pag-aaral para sa Bile Duct Cancer (Cholangiocarcinoma) sa ibang lungsod
- Houston, TX13 pag-aaral
- Boston, MA8 pag-aaral
- Rochester, MN7 pag-aaral
- Arlington, VA7 pag-aaral
- Los Angeles, CA7 pag-aaral
- Chicago, IL7 pag-aaral
- Columbus, OH6 pag-aaral
- Cleveland, OH6 pag-aaral
- Edison, NJ5 pag-aaral
- Queens, NY5 pag-aaral
- Grand Rapids, MI5 pag-aaral
- Nashville, TN5 pag-aaral
Iba pang pag-aaral sa New York City
- Kanser sa Suso136 pag-aaral
- Non-Small Cell Lung Cancer121 pag-aaral
- Kanser (lahat ng uri)109 pag-aaral
- Kanser sa Prostate103 pag-aaral
- Metastatic Cancer93 pag-aaral
- Colorectal Cancer78 pag-aaral
- Kanser sa Ovary69 pag-aaral
- Kanser sa Baga60 pag-aaral
- Multiple Myeloma60 pag-aaral
- Kanser sa Pancreas60 pag-aaral
- Kanser ng Endometrium52 pag-aaral
- Acute Myeloid Leukemia51 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.